Sign in
4

Changes in Ownership

Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-239240

Chief Operating Officer sold 2,176 shares at $19.00 ($41,344)

  • Chief Operating Officer acquired 2,176 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Champoux Jennifer · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-22 Exercise or conversion : show line 1 in the form 10b5-1 +2,176 $3.98 $8,660 64,547 D
2026-05-22 Sale : show line 2 in the form 10b5-1 −2,176 $19.00 $41,344 62,371 D
Open-market sales · 2,176 sh · avg $19.00 · $41,344

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-22 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −2,176 37,824 D
Loading xslF345X06/ownership.xml…